相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference
F. Roila et al.
ANNALS OF ONCOLOGY (2010)
A phase II study of palonosetron combined with dexamethasone to prevent nausea and vomiting induced by highly emetogenic chemotherapy
M. Maemondo et al.
ANNALS OF ONCOLOGY (2009)
A phase II dose-ranging study of palonosetron in Japanese patients receiving moderately emetogenic chemotherapy, including anthracycline and cyclophosphamide-based chemotherapy
Y. Segawa et al.
ANNALS OF ONCOLOGY (2009)
Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial
Mitsue Saito et al.
LANCET ONCOLOGY (2009)
High dose palonosetron does not alter ECG parameters including QTc interval in healthy subjects: results of a dose-response, double blind, randomized, parallel E14 study of palonosetron vs. moxifloxacin or placebo
J. Morganrothi et al.
EJC SUPPLEMENTS (2007)
American Society of Clinical Oncology Guideline for Antiemetics in Oncology: Update 2006
Mark G. Kris et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Rankings and symptom assessments of side effects from chemotherapy: insights from experienced patients with ovarian cancer
CC Sun et al.
SUPPORTIVE CARE IN CANCER (2005)
Improved prevention of moderately emetogenic chemotherapy-induced nausea and vomiting with palonosetron, a pharmacologically novel 5-HT3 receptor antagonist -: Results of a phase III, single-dose trial versus dolasetron
P Eisenberg et al.
CANCER (2003)
Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron
R Gralla et al.
ANNALS OF ONCOLOGY (2003)
分享论文
